Revenue + Forward P/E
Eli Lilly and Company (LLY) quarterly revenue and forward P/EForward P/E: 29.8x
RevenueRevenue (est)Forward P/E
Fair value & valuation models
Fair value models are a Plus feature
Upgrade to Plus for the interactive DCF model, valuation bands, and implied-price scenarios.
71% OFF$23.99 $6.99/mo
Ends in23:59:59
Cancel anytime. Secure checkout via Stripe.
Valuation
Market cap
$1.15T
Enterprise value
$1.16T
P/E ratio (TTM)
42.41x
P/S ratio (TTM)
15.59x
P/B ratio
34.29x
EV/Sales
16.12x
EV/EBITDA
34.80x
Dividend yield
0.54%
Income statement (TTM)
Revenue (TTM)
$65.18B
Gross profit (TTM)
$54.62B
Operating income (TTM)
$29.70B
EBITDA (TTM)
$27.94B
Net income (TTM)
$20.64B
Free cash flow (TTM)
$8.97B
Margins & returns
Gross margin
83.51%
Operating margin
45.87%
Profit margin
34.98%
Return on equity
101.30%
Return on assets
21.68%
Per-share metrics
EPS (TTM)
$28.26
Dividend yield
0.54%
Beta
0.51
Capital structure
Cash & equivalents
$7.16B
Total debt
$42.50B
Net debt
$35.34B
Shares outstanding
941.74M
Financial health
Current ratio
1.58
Debt / equity
1.60
Debt / assets
0.38
Interest coverage
37.34
| Company | Market cap | P/E | P/S | EV/EBITDA | Div yield |
|---|---|---|---|---|---|
| $1.15T | 42.41x | 15.59x | 34.80x | 0.54% | |
| $629.78B | 30.45x | 6.47x | 20.76x | 1.99% | |
| $443.08B | 127.13x | 7.29x | 30.82x | 2.63% | |
| $365.18B | 27.06x | 0.85x | 16.46x | 2.13% | |
| $354.73B | 23.91x | 4.80x | 15.14x | 2.67% | |
| $332.26B | 36.82x | 4.94x | 19.57x | 2.56% | |
| $289.30B | 23.55x | 5.38x | 15.27x | 2.92% |